Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
2.401
-0.059 (-2.40%)
Jun 3, 2026, 11:21 AM EDT - Market open
Moleculin Biotech Market Cap
Moleculin Biotech has a market cap or net worth of $12.81 million as of June 3, 2026. Its market cap has decreased by -3.67% in one year.
Market Cap
12.81M
Enterprise Value
3.14M
1-Year Change
-3.67%
Ranking
Category
Stock Price
$2.40
Market Cap Chart
Since June 2, 2016, Moleculin Biotech's market cap has decreased from $70.70M to $12.81M, a decrease of -81.88%. That is a compound annual growth rate of -15.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 13.10M | 95.52% |
| Dec 31, 2025 | 6.70M | 31.37% |
| Dec 31, 2024 | 5.10M | -80.08% |
| Dec 29, 2023 | 25.60M | -15.51% |
| Dec 30, 2022 | 30.30M | -43.05% |
| Dec 31, 2021 | 53.20M | 6.83% |
| Dec 31, 2020 | 49.80M | 19.14% |
| Dec 31, 2019 | 41.80M | 48.23% |
| Dec 31, 2018 | 28.20M | -28.24% |
| Dec 29, 2017 | 39.30M | 42.91% |
| Dec 30, 2016 | 27.50M | -61.10% |
| Jun 2, 2016 | 70.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jasper Therapeutics | 14.96M |
| HCW Biologics | 14.82M |
| SeaStar Medical Holding | 14.55M |
| Cadrenal Therapeutics | 14.47M |
| Moolec Science | 14.25M |
| AIM ImmunoTech | 14.15M |
| MetaVia | 14.10M |
| CytoMed Therapeutics | 13.50M |